Translational Development Acquisition Corp. (TDAC) · Nov 20, 2026 · Material agreement
$3.9B equity value — $3.9B equity value = $3.8B enterprise value + $100M net cash
TDAC’s merger amendment formalizes ProLogium’s $3.9B equity value, recapitalization and post-close voting control without changing the operating story.
ProLogium is a pre-scale solid-state battery developer: it is moving from Taiwan production toward commercialization while building a second gigafactory in Dunkirk, France. Its 2025 revenue was only $2.9 million against a $78.5 million operating loss, so this transaction remains primarily a funding-and-scale-up story rather than an established earnings story.
The amendment makes the transaction’s valuation and capitalization more precise, but does not re-rate the business. It sets ProLogium’s equity value at $3.9 billion, comprising $3.8 billion of enterprise value and $100 million of agreed net cash. The same 4.16 consolidation factor was already reflected in the transaction materials, so the headline valuation is more formalized than surprising.
The main new detail is the post-close control structure, not operating progress. ProLogium’s founder receives three board appointments, while multiple existing investors retain appointment rights and Class B shares carry twelve votes each versus one for Class A. 〔0〕 That gives investors a clearer picture of governance and voting concentration, but it does not improve production, revenue, or funding certainty.
Closing risk remains intact. The amendment defines what cash can count toward Available Cash and clarifies warrant treatment, but it neither closes the combination nor delivers the financing. The registration statement is still not effective, and the deal remains subject to shareholder approval, financing, listing and other closing conditions. The agreement otherwise remains unchanged. 〔1〕
Bottom line: This is a meaningful cleanup of the merger’s valuation, share mechanics and governance, but not a change to ProLogium’s underlying business trajectory. Relative to the already-announced transaction, it is mostly confirmation and added precision rather than a fresh catalyst.
TDAC shareholder vote after F-4 effectiveness
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!